Skip to main content

Table 3 Outcomes

From: Short term clinical outcomes and analysis of risk factors for pacemaker implantation: a single center experience of self-expandable TAVI valves

Procedural outcomes

 

30 day all cause mortality

5/88 (5.7%)

1 year actuarial all cause mortality

14/84 (16.7%)

Kaplan Meier 1 year all cause survival

83.3%

Causes of death (1 year) * n = 14

 

Sepsis

3/14 (21.4%)

Renal failure

1/14 (7.1%)

Pacing wire ventricular perforation

1/14 (7.1%)

Root rupture

1/14 (7.1%)

Myocardial infarction

3/14 (21.4%)

Congestive heart failure

2/14 (14.5%)

Stroke

3/14 (21.4%)

Cardiovascular death at 1 year

10/84 (11.9%)

Major Vascular complications

8/88 (8%)

Coronary obstruction

2/88 (2.3%)

30 day disabling stroke risk

5/88 (5.7%)

30 day Acute kidney injury with renal replacement therapy

6/88 (6.8%)

Device success rate (defined as single valve,with no moderate to severe PVL, mean gradient < 20 mmHg)

88.6%

1 year Prosthetic valve endocarditis

2/84 (2.4%)

1 year Repeat valvular intervention

1/84 (1.2%)

30 Day Pacemaker rates (n = 85 *3 cases of pre op PPM excluded)

15/85 (17.6%)

Moderate or more paravalvular leak (PVL) on 1 year echocardiogram

5/84 (6.0%)

Repeated cardiac events (angina, MI, heart failure) requiring admissions within 1 year

7/84 (8.3%)